University of Tokyo researchers have created a powerful new microscope that captures both forward- and back-scattered light at once, letting scientists see everything from large cell structures to tiny nanoscale particles in a single shot.
Researchers at the University of Tokyo have developed a new type of microscope that can detect signals over an intensity range 14 times broader than that of standard microscopes. The technique works label-free, meaning it does not require extra fluorescent dyes or stains. Because of this, the method is gentle on living cells and suitable for long-term monitoring, making it attractive for testing and quality control in pharmaceutical and biotechnology settings. The work is described today (November 14) in the journal Nature Communications.
Balancing Sensitivity and Scale in Modern Imaging
Microscopes have been essential tools for scientific discovery since the 16th century, but each major advance has typically required instruments that are not only more precise, but also more specialized. As a result, today's advanced imaging methods often involve difficult tradeoffs between what they can see and how they see it. Quantitative phase microscopy (QPM) uses forward-scattered light to detect structures at the microscale (in this study, over 100 nanometers), but it cannot access much smaller features.
In practice, QPM is often used to capture still images of complex cellular architecture. Interferometric scattering (iSCAT) microscopy takes a different approach by relying on back-scattered light and can pick up structures as tiny as single proteins. This makes it powerful for "tracking" individual particles and following rapid changes inside cells, but it does not offer the broad, whole-cell perspective that QPM provides.
Dual-Direction Light Measurement Strategy
"I would like to understand dynamic processes inside living cells using non-invasive methods," says Horie, one of the first authors.
Guided by this goal, the team explored whether collecting light traveling in both directions simultaneously could break the usual trade-off and capture a wide range of particle sizes and motions in a single frame. To evaluate this idea and verify that their custom-built microscope was working as intended, they focused on what happens during cell death. In one experiment, they recorded a single image that contained information from both forward- and backward-traveling light.
Separating Signals With High Precision
"Our biggest challenge," Toda, another first author, explains, "was cleanly separating two kinds of signals from a single image while keeping noise low and avoiding mixing between them."
By carefully processing the data, the researchers succeeded in measuring the movement of larger cell components (micro) as well as much smaller particles (nano). Comparing the forward- and back-scattered signals also allowed them to estimate each particle's size and its refractive index, a property that describes how strongly light bends or scatters when it encounters the particle.
Toward Imaging Exosomes and Viruses
"We plan to study even smaller particles," Toda says, already thinking about future research, "such as exosomes and viruses, and to estimate their size and refractive index in different samples. We also want to reveal how living cells move toward death by controlling their state and double-checking our results with other techniques."
Reference: "Bidirectional quantitative scattering microscopy" 14 November 2025, Nature Communications.
DOI: 10.1038/s41467-025-65570-w
News
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]















